Stay updated on Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial
Sign up to get notified when there's something new on the Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial page.

Latest updates to the Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial page
- Check5 days agoChange DetectedThe site revision identifier was updated from v3.7.2 to v3.8.0. The study record page still displays a 403 error.SummaryDifference0.2%

- Check12 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check19 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2. The page continues to show a 403 Forbidden error instead of the study results.SummaryDifference0.2%

- Check26 days agoChange DetectedThe error page’s footer revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden message.SummaryDifference0.2%

- Check40 days agoChange DetectedThe results page now shows a 403 Forbidden message with HTML indicating blocked access, replacing the usual study content. This indicates the page is temporarily unavailable due to access restrictions.SummaryDifference25%

- Check47 days agoChange DetectedThe page’s revision metadata was updated to Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates a new update to the page’s revision history.SummaryDifference0.0%

Stay in the know with updates to Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial page.